Method of treating conditions susceptible to modulation of NPY receptors with diarylimidazole derivatives
US6121260A · kind A · utility
7Cited by
12References
43Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 2, 1998 |
| Grant date | Sep 19, 2000 |
| Priority date | — |
| Expiry date | Jul 2, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Certain diaryl imidazoles act as partial agonists or antagonists for NPY receptors, in particular NPY 5 receptors. They are of use, for example in treating loss of appetite. Such compounds bear aryl groups in the 2 position. Many of the compounds are novel.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.